Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03025451 · ClinicalTrials.gov registry record · NA
Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) Database
A NA study, sponsored by Ohio University.
- Completed
- Registry status
- NA
- Development phase
- 512
- Enrollment target
NCT03025451: Completed NA study, sponsored by Ohio University.
NCT03025451 is a NA study that has completed, run by Ohio University. The registered enrollment target is 512 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03025451, a NA study, has completed, sponsored by Ohio University.
- COMPLETED
- Registry status
- NA
- Development phase
- 512 participants
- Enrollment target
Study Summary
Data from participants in Athens CHIP classes from May 2011 to present will be analyzed to evaluate the differences in outcomes based on: 1) gender, 2) age, 3) whether a household member participated in the class with them. Participants had health screens before and after completing the class. The data from the health screens that will be utilized for comparison will include: body mass index (BMI), blood pressure, and fasting blood sugar and lipid levels.
Primary Outcome
Weight
Interventions
- BEHAVIORAL The Complete Health Improvement Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2011-05 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT03025451 record still lists
NCT03025451 is an interventional study that assigns participants to a tested intervention. The registered 512 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 1 intervention - of which The Complete Health Improvement Program is the first listed.
NCT03025451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03025451 about?
NCT03025451 is a clinical study titled "Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) Database". Data from participants in Athens CHIP classes from May 2011 to present will be analyzed to evaluate the differences in outcomes based on: 1) gender, 2) age, 3) whether a household member participated in the class with them. Participants had health screens before and after completing the class. The ...
What is the current status of trial NCT03025451?
This trial is currently completed. It is a NA study. The enrollment target is 512 participants. The study started on 2011-05. Estimated completion is 2016-03.
What interventions are being tested in trial NCT03025451?
The interventions under investigation include: The Complete Health Improvement Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03025451?
This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03025451's enrollment target sits among peer trials
512 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia